FI940030L - Uusi menetelmä imidatsolin rikkijohdannaisten valmistamiseksi ja uusiavälituotteita - Google Patents
Uusi menetelmä imidatsolin rikkijohdannaisten valmistamiseksi ja uusiavälituotteita Download PDFInfo
- Publication number
- FI940030L FI940030L FI940030A FI940030A FI940030L FI 940030 L FI940030 L FI 940030L FI 940030 A FI940030 A FI 940030A FI 940030 A FI940030 A FI 940030A FI 940030 L FI940030 L FI 940030L
- Authority
- FI
- Finland
- Prior art keywords
- new
- imidazole
- preparation
- sulfur derivatives
- intermediates
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
- C07D233/58—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
- C07C311/18—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by nitrogen atoms, not being part of nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/37—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/50—Compounds containing any of the groups, X being a hetero atom, Y being any atom
- C07C311/51—Y being a hydrogen or a carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/50—Compounds containing any of the groups, X being a hetero atom, Y being any atom
- C07C311/52—Y being a hetero atom
- C07C311/54—Y being a hetero atom either X or Y, but not both, being nitrogen atoms, e.g. N-sulfonylurea
- C07C311/57—Y being a hetero atom either X or Y, but not both, being nitrogen atoms, e.g. N-sulfonylurea having sulfur atoms of the sulfonylurea groups bound to carbon atoms of six-membered aromatic rings
- C07C311/58—Y being a hetero atom either X or Y, but not both, being nitrogen atoms, e.g. N-sulfonylurea having sulfur atoms of the sulfonylurea groups bound to carbon atoms of six-membered aromatic rings having nitrogen atoms of the sulfonylurea groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C327/00—Thiocarboxylic acids
- C07C327/58—Derivatives of thiocarboxylic acids, the doubly-bound oxygen atoms being replaced by nitrogen atoms, e.g. imino-thio ethers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/84—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Epoxy Resins (AREA)
- Crystals, And After-Treatments Of Crystals (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9312413A FR2711367B1 (fr) | 1993-10-19 | 1993-10-19 | Nouveau procédé de préparation de dérivés soufrés de l'imidazole et les nouveaux intermédiaires obtenus. |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI940030A0 FI940030A0 (fi) | 1994-01-04 |
| FI940030A7 FI940030A7 (fi) | 1995-04-20 |
| FI940030L true FI940030L (fi) | 1995-04-20 |
Family
ID=9451963
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI940030A FI940030L (fi) | 1993-10-19 | 1994-01-04 | Uusi menetelmä imidatsolin rikkijohdannaisten valmistamiseksi ja uusiavälituotteita |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US5527919A (fi) |
| EP (1) | EP0648763B1 (fi) |
| JP (1) | JP3723585B2 (fi) |
| KR (1) | KR950011414A (fi) |
| CN (1) | CN1097419A (fi) |
| AT (1) | ATE201022T1 (fi) |
| AU (1) | AU676221B2 (fi) |
| BR (1) | BR9400015A (fi) |
| CA (1) | CA2112871A1 (fi) |
| CZ (1) | CZ1194A3 (fi) |
| DE (1) | DE69427179T2 (fi) |
| DK (1) | DK0648763T3 (fi) |
| ES (1) | ES2157962T3 (fi) |
| FI (1) | FI940030L (fi) |
| FR (1) | FR2711367B1 (fi) |
| GR (1) | GR3036053T3 (fi) |
| HR (1) | HRP940005A2 (fi) |
| HU (1) | HUT67915A (fi) |
| IL (1) | IL108200A0 (fi) |
| NO (1) | NO940019L (fi) |
| NZ (1) | NZ250601A (fi) |
| PL (1) | PL301776A1 (fi) |
| PT (1) | PT648763E (fi) |
| RU (1) | RU2135475C1 (fi) |
| SI (1) | SI9400018A (fi) |
| SK (1) | SK494A3 (fi) |
| YU (1) | YU48685B (fi) |
| ZA (1) | ZA9420B (fi) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2716882B1 (fr) * | 1994-03-04 | 1996-04-05 | Roussel Uclaf | Utilisation de dérivés de l'imidazole au traitement d'affections impliquant les récepteurs AT1 et AT2 de l'Angiotensine, certains de ces produits, leur préparation, compositions pharmaceutiques. |
| AU1600297A (en) * | 1996-02-15 | 1997-09-02 | Novartis Ag | Aryl derivatives |
| US6063930A (en) * | 1996-04-03 | 2000-05-16 | Merck & Co., Inc. | Substituted imidazole compounds useful as farnesyl-protein transferase inhibitors |
| US6080870A (en) * | 1996-04-03 | 2000-06-27 | Merck & Co., Inc. | Biaryl substituted imidazole compounds useful as farnesyl-protein transferase inhibitors |
| EP0855392A3 (de) | 1997-01-22 | 2000-01-05 | Hoechst Aktiengesellschaft | Fünfgliedrige Heterocyclen mit Biphenylsulfonylsubstitution, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| AU4844699A (en) * | 1998-07-01 | 2000-01-24 | Merck & Co., Inc. | Process for making 1,5-disubstituted imidazoles |
| DE19832429A1 (de) * | 1998-07-18 | 2000-01-20 | Hoechst Marion Roussel De Gmbh | Imidazolderivate mit Biphenylsulfonylsubstitution, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| DE19832428A1 (de) | 1998-07-18 | 2000-01-20 | Hoechst Marion Roussel De Gmbh | Imidazolderivate mit Biphenylsulfonylsubstitution, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| US8236843B2 (en) | 2008-09-02 | 2012-08-07 | Elder Pharmaceuticals Ltd. | Anti inflammatory compounds |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATA937274A (de) * | 1973-12-17 | 1978-02-15 | Thomae Gmbh Dr K | Verfahren zur herstellung neuer araliphatischer ketone |
| PH30484A (en) * | 1990-02-19 | 1997-05-28 | Ciba Geigy | Acy compounds pharmaceutical composition containing said compound and method of use thereof |
| TW201738B (fi) * | 1990-03-20 | 1993-03-11 | Sanofi Co | |
| IL98319A (en) * | 1990-07-05 | 1997-04-15 | Roussel Uclaf | Sulphurous derivatives of imidazole, their preparation process, and pharmaceutical compositions containing them |
| CA2058198A1 (en) * | 1991-01-04 | 1992-07-05 | Adalbert Wagner | Azole derivatives, process for their preparation, and their use |
| IE920175A1 (en) * | 1991-02-11 | 1992-08-12 | Zeneca Ltd | Nitrogen heterocycles |
| TW209213B (fi) * | 1991-08-21 | 1993-07-11 | Yamanouchi Pharma Co Ltd | |
| EP0550313A1 (fr) * | 1991-12-30 | 1993-07-07 | Synthelabo | Nouveaux dérivés de 2-(tétrazol-5-yl)-(1,1'-biphényle), leur préparation et leur utilisation comme intermédiaires de synthèse |
-
1993
- 1993-10-19 FR FR9312413A patent/FR2711367B1/fr not_active Expired - Fee Related
- 1993-12-23 NZ NZ250601A patent/NZ250601A/en unknown
- 1993-12-27 IL IL10820093A patent/IL108200A0/xx unknown
- 1993-12-29 JP JP35413293A patent/JP3723585B2/ja not_active Expired - Fee Related
- 1993-12-29 YU YU82393A patent/YU48685B/sh unknown
- 1993-12-30 RU RU93057747A patent/RU2135475C1/ru active
-
1994
- 1994-01-03 HR HR9312413A patent/HRP940005A2/xx not_active Application Discontinuation
- 1994-01-04 DK DK94400008T patent/DK0648763T3/da active
- 1994-01-04 CN CN94100188A patent/CN1097419A/zh active Pending
- 1994-01-04 HU HU9400017A patent/HUT67915A/hu unknown
- 1994-01-04 SK SK4-94A patent/SK494A3/sk unknown
- 1994-01-04 NO NO940019A patent/NO940019L/no unknown
- 1994-01-04 EP EP94400008A patent/EP0648763B1/fr not_active Expired - Lifetime
- 1994-01-04 PL PL94301776A patent/PL301776A1/xx unknown
- 1994-01-04 ES ES94400008T patent/ES2157962T3/es not_active Expired - Lifetime
- 1994-01-04 FI FI940030A patent/FI940030L/fi unknown
- 1994-01-04 BR BR9400015A patent/BR9400015A/pt not_active Application Discontinuation
- 1994-01-04 CZ CZ9411A patent/CZ1194A3/cs unknown
- 1994-01-04 AT AT94400008T patent/ATE201022T1/de not_active IP Right Cessation
- 1994-01-04 KR KR1019940000059A patent/KR950011414A/ko not_active Ceased
- 1994-01-04 US US08/177,153 patent/US5527919A/en not_active Expired - Lifetime
- 1994-01-04 AU AU53004/94A patent/AU676221B2/en not_active Ceased
- 1994-01-04 DE DE69427179T patent/DE69427179T2/de not_active Expired - Fee Related
- 1994-01-04 PT PT94400008T patent/PT648763E/pt unknown
- 1994-01-04 ZA ZA9420A patent/ZA9420B/xx unknown
- 1994-01-05 CA CA002112871A patent/CA2112871A1/fr not_active Abandoned
- 1994-01-18 SI SI9400018A patent/SI9400018A/sl unknown
-
2001
- 2001-06-14 GR GR20010400895T patent/GR3036053T3/el not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI945441L (fi) | Uusi menetelmä 7beta-substituoitu-4-atsa-5alfa-androstan-3-onien valmistamiseksi | |
| FI945900A7 (fi) | Bentseenisulfonamidijohdokset ja menetelmä näiden valmistamiseksi | |
| FI960751A7 (fi) | Substituoidut atsaindolylideeniyhdisteet ja menetelmä niiden valmistamiseksi | |
| FI973426L (fi) | Bentsopyraania sisältävät yhdisteet ja menetelmä niiden valmistamiseksi | |
| PT98638A (pt) | Processo para a preparacao de derivados de borsolina | |
| FI954246L (fi) | Uusia A83543-yhdisteitä ja menetelmä niiden valmistamiseksi | |
| FI941137L (fi) | 2-debentsoyyli-2-asyylitaksolijohdannaisia ja menetelmiä niiden valmistamiseksi | |
| FI925883A7 (fi) | Menetelmä ei-syntaasin ja syklo-oksygenaasin kaksoisinhibiittorien valmistamiseksi | |
| BR9510256A (pt) | Derivados de ácido 3-aril-tetrônico | |
| FI943384L (fi) | Menetelmä lahjoitusten suorittamiseksi ja keräämiseksi | |
| FI982790A0 (fi) | Menetelmä klavulaanihapon valmistamiseksi | |
| FI953645L (fi) | Menetelmä taksaanijohdannaisten valmistamiseksi sekä niiden B-laktaaminivälituotteet | |
| FI96317C (fi) | Menetelmä hienojakoisten ja muunnettujen tärkkelyksien valmistamiseksi | |
| FI940029A7 (fi) | Uusi menetelmä imidatsolin rikkijohdannaisten valmistamiseksi ja uusia välituotteita | |
| FI891933A7 (fi) | Menetelmä ja välituotteet terapeuttisesti hyödyllisten hydantoiinijohdannaisten valmistamiseksi | |
| FI940030L (fi) | Uusi menetelmä imidatsolin rikkijohdannaisten valmistamiseksi ja uusiavälituotteita | |
| FI896096A7 (fi) | Menetelmä piperidiinidionijohdannaisten pelkistämiseksi ja välituotteita | |
| FI931346A7 (fi) | Butadieenijohdokset ja menetelmä niiden valmistamiseksi | |
| ITMI950151A0 (it) | Nuovi derivati dell'acido kojico | |
| FI970564L (fi) | Uusi menetelmä di-isopinokamfeyyliklooriboraanin valmistamiseksi | |
| FI952718A7 (fi) | Uusi menetelmä 16beta-metyylisteroidin ja uusien välituotteiden valmistamiseksi | |
| FI973434A7 (fi) | Aminotetralonijohdannaisia ja menetelmä niiden valmistamiseksi | |
| ITMI942319A0 (it) | Nuovi derivati dell'acido kojico | |
| FI944842A0 (fi) | Fluoratut 4-aminoandrostadienonijohdannaiset ja menetelmä niiden valmistamiseksi | |
| FI981359L (fi) | Uudet tiomarinolin johdannaiset ja menetelmät niiden valmistamiseksi |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GB | Transfer or assigment of application |
Owner name: HOECHST MARION ROUSSEL |